Krugman.
… This is really unbelievable:
The drug and medical-device industries are mobilizing to gut a provision in the stimulus bill that would spend $1.1 billion on research comparing medical treatments, portraying it as the first step to government rationing.
Because freedom is all about laying out vast sums on medical treatments without knowing whether they’re actually doing any good. …
Update, also Krugman:
Good news: Congress has defied the efforts of drug companies and medical-device producers to strip comparative effectiveness research from the stimulus bill. One small victory for sanity and justice.